Why is Roche stock so low?
I'm curious to understand why the share price of Roche, a reputable pharmaceutical company, has been trading at such a low level. Could it be due to concerns over their recent product pipeline or the impact of global economic conditions on the healthcare sector? Is there any news or regulatory changes that have contributed to this trend? I'm looking for insights into the factors driving this underperformance and potential opportunities for investors in the future.